Bruna David, Medical Oncologist at Brazil’s National Cancer Institute (INCA), shared on LinkedIn:
“Last week, I had the privilege of representing Brazil in an insightful discussion on how international collaboration can translate scientific innovation into patient benefit, at the China Anti-Cancer Association (CACA) Congress, in Changsha.
The International Alliance for Personalised Medicine, in partnership with CACA, is tackling a critical challenge in cancer care: moving from innovation to implementation, without creating yet another form of inequality.”

You can also read:
SIOG and CACA Establish New Partnership to Take The Geriatric Oncology Mission Global